These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24407918)

  • 1. Crystal structures and kinetic properties of enoyl-acyl carrier protein reductase I from Candidatus Liberibacter asiaticus.
    Jiang L; Gao Z; Li Y; Wang S; Dong Y
    Protein Sci; 2014 Apr; 23(4):366-77. PubMed ID: 24407918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The genome of a Bacteroidetes inhabitant of the human gut encodes a structurally distinct enoyl-acyl carrier protein reductase (FabI).
    Radka CD; Frank MW; Yao J; Seetharaman J; Miller DJ; Rock CO
    J Biol Chem; 2020 May; 295(22):7635-7652. PubMed ID: 32317282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural insights into the dimer-tetramer transition of FabI from Bacillus anthracis.
    Kim HT; Kim S; Na BK; Chung J; Hwang E; Hwang KY
    Biochem Biophys Res Commun; 2017 Nov; 493(1):28-33. PubMed ID: 28935372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the Francisella tularensis enoyl-acyl carrier protein reductase (FabI) in complex with NAD(+) and triclosan.
    Mehboob S; Truong K; Santarsiero BD; Johnson ME
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1436-40. PubMed ID: 21045289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of Enoyl-ACP reductases I (FabI) and III (FabL) from B. subtilis.
    Kim KH; Ha BH; Kim SJ; Hong SK; Hwang KY; Kim EE
    J Mol Biol; 2011 Feb; 406(3):403-15. PubMed ID: 21185310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution structures of Thermus thermophilus enoyl-acyl carrier protein reductase in the apo form, in complex with NAD+ and in complex with NAD+ and triclosan.
    Otero JM; Noël AJ; Guardado-Calvo P; Llamas-Saiz AL; Wende W; Schierling B; Pingoud A; van Raaij MJ
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Oct; 68(Pt 10):1139-48. PubMed ID: 23027736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and Biochemical Studies on Klebsiella Pneumoniae Enoyl-ACP Reductase (FabI) Suggest Flexible Substrate Binding Site.
    Biswas S; Patra A; Paul P; Misra N; Kushwaha GS; Suar M
    Protein J; 2024 Feb; 43(1):84-95. PubMed ID: 38127182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
    Massengo-Tiassé RP; Cronan JE
    J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism and inhibition of the FabV enoyl-ACP reductase from Burkholderia mallei.
    Lu H; Tonge PJ
    Biochemistry; 2010 Feb; 49(6):1281-9. PubMed ID: 20055482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
    Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
    Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Enoyl-Acyl Carrier Protein Reductase Structure and Interactions Yields an Efficient Virtual Screening Approach and Suggests a Potential Allosteric Site.
    Ghattas MA; Mansour RA; Atatreh N; Bryce RA
    Chem Biol Drug Des; 2016 Jan; 87(1):131-42. PubMed ID: 26259619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The enoyl-[acyl-carrier-protein] reductases FabI and FabL from Bacillus subtilis.
    Heath RJ; Su N; Murphy CK; Rock CO
    J Biol Chem; 2000 Dec; 275(51):40128-33. PubMed ID: 11007778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization and preliminary X-ray crystallographic studies of enoyl-acyl carrier protein reductase (FabI) from Psuedomonas aeruginosa.
    Lee JH; Park AK; Chi YM; Moon JH; Lee KS
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2011 Feb; 67(Pt 2):214-6. PubMed ID: 21301088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AFN-1252 is a potent inhibitor of enoyl-ACP reductase from Burkholderia pseudomallei--Crystal structure, mode of action, and biological activity.
    Rao KN; Lakshminarasimhan A; Joseph S; Lekshmi SU; Lau MS; Takhi M; Sreenivas K; Nathan S; Yusof R; Abd Rahman N; Ramachandra M; Antony T; Subramanya H
    Protein Sci; 2015 May; 24(5):832-40. PubMed ID: 25644789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FabI (enoyl acyl carrier protein reductase) - A potential broad spectrum therapeutic target and its inhibitors.
    Rana P; Ghouse SM; Akunuri R; Madhavi YV; Chopra S; Nanduri S
    Eur J Med Chem; 2020 Dec; 208():112757. PubMed ID: 32883635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of acyl carrier protein bound to FabI, the FASII enoyl reductase from Escherichia coli.
    Rafi S; Novichenok P; Kolappan S; Stratton CF; Rawat R; Kisker C; Simmerling C; Tonge PJ
    J Biol Chem; 2006 Dec; 281(51):39285-39293. PubMed ID: 17012233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enoyl-[acyl-carrier-protein] reductase (FabI) of Escherichia coli, which catalyzes a key regulatory step in fatty acid biosynthesis, accepts NADH and NADPH as cofactors and is inhibited by palmitoyl-CoA.
    Bergler H; Fuchsbichler S; Högenauer G; Turnowsky F
    Eur J Biochem; 1996 Dec; 242(3):689-94. PubMed ID: 9022698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical and structural basis for Moraxella catarrhalis enoyl-acyl carrier protein reductase (FabI) inhibition by triclosan and estradiol.
    Katiki M; Neetu N; Pratap S; Kumar P
    Biochimie; 2022 Jul; 198():8-22. PubMed ID: 35276316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural and enzymatic analyses reveal the binding mode of a novel series of Francisella tularensis enoyl reductase (FabI) inhibitors.
    Mehboob S; Hevener KE; Truong K; Boci T; Santarsiero BD; Johnson ME
    J Med Chem; 2012 Jun; 55(12):5933-41. PubMed ID: 22642319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents.
    Muench SP; Prigge ST; McLeod R; Rafferty JB; Kirisits MJ; Roberts CW; Mui EJ; Rice DW
    Acta Crystallogr D Biol Crystallogr; 2007 Mar; 63(Pt 3):328-38. PubMed ID: 17327670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.